top of page
Blue Skies

World's Only Cloud Lab, HTE, & Lab Automation Virtual Conference 2023

Dates: December 5-6, 2023

Start Time: 10 a.m. ET / 7 a.m. PT

We are bringing together the relevant individuals and organizations for the 3rd Annual Cloud Lab, High Throughput Experimentation, and Lab Automation Conference.

We are pivoting the typical conference approach by reducing the tracks and bringing the most interesting talks with a better attendee experience.

 

  • Daily round table summaries

  • Keynotes

  • Industry and academic speakers

  • Sponsorship levels to meet your budget

  • Optional virtual Vendor Showcase booth

Event Sponsors

ACD/Labs
LabVoice logo
Strateos Logo
Virscidian logo
Revvity Signals
Monomer Bio
XavoLogo
StableBody Tech Logo
BASF
AstraZeneca
Artitificial logo
Takeda
Arctoris
Singh Instruments Logo.jpeg
Sila
Agenda Tuesday, December 5th
Agenda Tuesday, December 5th

Event Speakers

Chris Stumpf Teams Profile

Chris Stumpf, PhD

Senior Principal Marketing Professional

Revvity Signals

WORLDWIDE

Talk Title:

Accelerating Scientific Data Capture, Improving Data Management and Analysis with a Comprehensive Digital Research Platform

Abstract:

How does a potential hit compound evolve into a lead and then a potential drug candidate? In the pursuit of successful drug candidates, many are made and must be tested throughout the discovery, clinical and regulatory approval stages. The development of a novel drug candidate requires engagement of various scientific expertise domains including chemistry, biology, bioinformatics, pharmacology and ADME/PK. Often these domain experts work in disparate locations or even disparate companies. This presentation will illustrate how using a comprehensive digital research platform, Signals Research Suite, enables researchers across scientific domains and geographies to collaborate better and manage the entire Make-Test-Decide R&D life cycle. Our presentation will cover how Signals Research Suite can help facilitate lead optimization to drug candidate triage, with Signals Notebook (Make); content data capture and collaboration with Signals Vitro Vivo (Test); and results – data-driven scientific decisions with Signals Inventa (Decide), all within a single platform.

Nikki Dare_ACD Labs

Nikki Dare, PhD

Katalyst D2D Product Manager

ACD/Labs

WORLDWIDE

Talk Title:

Case Studies: Improving Experiment Design and Automation of Analytical Data Processing and Management in HTE

Abstract:

Automation and high throughput synthesis (more generally referred to as High Throughput Experimentation—HTE) with the help of robotics has allowed scientists to significantly increase experiment output and, subsequently, the amount of analytical data collected, in shorter periods of time. Many solutions for managing HT experiments require the use of multiple software systems, as well as transfer of data between these systems. We will present how purpose-built HTE software is being used to facilitate experiment design and automated targeted analytical data processing for different HTE workflows.

Zev Wisotsky, PhD_Headshot

Zev Wisotsky, PhD

Senior Principal Marketing Manager

Revvity Signals

WORLDWIDE

Talk Title:

Accelerating Scientific Data Capture, Improving Data Management and Analysis with a Comprehensive Digital Research Platform

Abstract:

How does a potential hit compound evolve into a lead and then a potential drug candidate? In the pursuit of successful drug candidates, many are made and must be tested throughout the discovery, clinical and regulatory approval stages. The development of a novel drug candidate requires engagement of various scientific expertise domains including chemistry, biology, bioinformatics, pharmacology and ADME/PK. Often these domain experts work in disparate locations or even disparate companies. This presentation will illustrate how using a comprehensive digital research platform, Signals Research Suite, enables researchers across scientific domains and geographies to collaborate better and manage the entire Make-Test-Decide R&D life cycle. Our presentation will cover how Signals Research Suite can help facilitate lead optimization to drug candidate triage, with Signals Notebook (Make); content data capture and collaboration with Signals Vitro Vivo (Test); and results – data-driven scientific decisions with Signals Inventa (Decide), all within a single platform.

Dan Rines_Headshot

Dan Rines, PhD

VP Technology Enabling & Digital Transformation Services

Strateos

WORLDWIDE

Talk Title:

Leveraging Wet Lab Automation in Integrated End-to-End Drug Discovery

Abstract:

In this presentation, we will explore the transformative potential of leveraging wet lab automation in drug discovery. Pioneered by companies like Strateos and Arctoris, developing integrated, automated drug discovery processes on demand is a paradigm shift for the biotech and pharma industry.

 

The talk will explore the development and evolution of Strateos’ platform, software, and process capabilities, as well as the development and evolution of Arctoris’ Ulysses platform. The unique potential of integrated wet lab automation will come to life with case studies and practical examples highlighting successful use cases accelerating both small molecule and biologics discovery.

 

Finally, the talk will also present a view towards the future, including current trends, on-going developments, and partnerships on the horizon.

John Walzer_Headshot

John Walzer, PhD

Scientific Advisor

Singh Instruments

WORLDWIDE

Talk Title:

Expanding the Process Parameter Space for High Throughput Screening in Chemistry

Abstract:

Mark Spears_Headshot

Mark Spears, PhD

Senior Scientist

Virscidian Inc.

WORLDWIDE

Talk Title:

Streamlined Design to Results with the Analytical Studio Platform

Abstract:

An integrated and automated approach to high-throughput experimentation (HTE) has been an industry goal for many years. The presentation will highlight how Virscidian’s Analytical Studio platform is directly addressing these challenges. With modern API’s, an open data approach, and excellent tools both for experimental design and data processing, this goal is within reach. In particular, Virscidian’s new Experiment Builder application adds a critical piece in this workflow, allowing scientists to design their plates and automate much of the sample analysis.

Florian Tauchert_Headshot

Florian Tauchert

VP of Engineering

Xavo

WORLDWIDE

Talk Title:Navigating Lab Disruptions: A story of Lab Ops Scheduling Success

Abstract:

In this presentation, we illuminate a critical challenge faced by laboratories in the pharmaceutical R&D domain—a scheduling problem exacerbated by unforeseen hardware failure. Delving into a case study from a client, we navigate through the chaos that ensued when a high-throughput automated store malfunctioned for several days, leading to a backlog of orders. Our focus lies on the transformative role of our scheduling system in mitigating this crisis. By orchestrating the prioritization of tasks, preventing parallel bookings of shared resources, and offering foresight into upcoming schedules, the scheduling solution emerged as the main contributor for restoring order. Join us as we dissect this real-world scenario, underscoring the indispensable nature of advanced scheduling methodologies in the face of operational disruptions.

Harry Horn_StableBody_Headshot

Harry Horn, PhD

Co-Founder, CEO, & COO

StableBody Tech

WORLDWIDE

Talk Title:

The Impact of BioDesign on BioManufacturing

Abstract:

StableBody Technologies LLC, is revolutionizing the bio-processing industry with their proprietary “Universal Rational Protein BioDesign Using Proprietary Thermodynamic Stabilization of Proteins”. This innovative technology utilizes unique and powerful algorithms to generate amino acid sequences for structurally and functionally improved antibody protein products (Cold Chain Free™). With the introduction of AffiBio-UIA™, scientists have access to this cutting-edge technology, providing greater control over the design process while significantly reducing development and processing time and cost.

Nikhita Singh_Headshot

Nikhita Singh, PhD

Co-Founder, CPO & Board Member

Artificial, Inc.

WORLDWIDE

Talk Title:

Empowering Biotech Innovation: Enabling Closed-Loop Labs with Artificial's Orchestration Platform

Abstract:

This talk will explore how Artificial's platform reshapes the traditional lab environment—transitioning from manual, error-prone processes to a seamlessly integrated, closed-loop system. Attendees will gain insights into how the platform's key features, such as digital twins, interactive SOPs, and flexible workflow tools, enable more efficient, accurate, and scalable lab operations. By leveraging Artificial's unique capabilities, including its powerful LabOps and extensive suite of adaptors, biotech labs can achieve unprecedented levels of data accuracy, operational efficiency, and experiment repeatability.

Kelcy Newell_Headshot

Kelcy Newell, PhD

Sr. Director, Robotics & Automation Development

AstraZeneca

WORLDWIDE

Talk Title:

Lab Automation & Robotics "Chalk Talk"

Sam Berg

Sam Alberg

Account Executive

Monomer Bio

WORLDWIDE

Talk Title:

Stem Cell Culture Automation in Support of Your Drug Development Pipeline

Abstract:

Join Monomer Bio for a presentation on stem cell culture automation and the creation of novel, iPSC-derived disease models. Monomer will discuss their unique approach to lab automation software and review their data-centric solutions for automated cell culture. This presentation will include a live demonstration of the Monomer software platform and a discussion of the impacts of stem cell culture automation on our customer's drug development pipelines.

Adrian Ramirez_Heashot

Adrian Galilea, PhD

Senior Lab Automation Scientist

Takeda

WORLDWIDE

Talk Title:

HTE & Automation to Accelerate Synthetic Molecules R&D

Abstract:

Brian London_Headshot

Brian London, PhD

Chief Software Engineer

StableBody Tech

WORLDWIDE

Talk Title:

The Impact of BioDesign on BioManufacturing

Abstract:

StableBody Technologies LLC, is revolutionizing the bio-processing industry with their proprietary “Universal Rational Protein BioDesign Using Proprietary Thermodynamic Stabilization of Proteins”. This innovative technology utilizes unique and powerful algorithms to generate amino acid sequences for structurally and functionally improved antibody protein products (Cold Chain Free™). With the introduction of AffiBio-UIA™, scientists have access to this cutting-edge technology, providing greater control over the design process while significantly reducing development and processing time and cost.

Amanda Savidge_Headshot

Amanda Savidge

Senior Account Executive

LabVoice

WORLDWIDE

Talk Title:

The Human Element of Data Entry: Laboratory Orchestration with a Scientist-Centric Approach

Abstract:

You walk into a cell culture laboratory, what do you see? Benches, incubators, PCR cyclers, flasks, bioreactors, pipettes, media…and people. Critically, scientists and technicians will continue to be key to laboratory task execution and their data recording process hasn’t changed in decades. In many cases, observations and data are still recorded on paper notebooks and later transcribed into another digital system (ELN, spreadsheets, etc). LabVoice has created tools to take these scientist-centric lab activities and change where, when, and how data can be recorded. Using a mobile-app based platform, LabVoice uses a number of connected inputs, including voice, to create a novel data entry platform. This presentation will walk you through the capabilities and benefits of a digital laboratory assistant. Hear about how LabVoice can enrich research data to support laboratory insights for process optimization and enable automation that takes direct inputs from the scientists at the bench.

Martin-Immanuel Bittner_Headshot.

Martin-Immanuel Bittner, MD, PhD

Co-Founder & CEO

Arctoris

WORLDWIDE

Talk Title:

Leveraging Wet Lab Automation in Integrated End-to-End Drug Discovery

Abstract:

In this presentation, we will explore the transformative potential of leveraging wet lab automation in drug discovery. Pioneered by companies like Strateos and Arctoris, developing integrated, automated drug discovery processes on demand is a paradigm shift for the biotech and pharma industry.

 

The talk will explore the development and evolution of Strateos’ platform, software, and process capabilities, as well as the development and evolution of Arctoris’ Ulysses platform. The unique potential of integrated wet lab automation will come to life with case studies and practical examples highlighting successful use cases accelerating both small molecule and biologics discovery.

 

Finally, the talk will also present a view towards the future, including current trends, on-going developments, and partnerships on the horizon.

Patrick Courtney Headshot

Patrick Courtney, PhD

Member Board of Directors; Marketing Lead

SiLA

WORLDWIDE

Talk Title:

Interoperability Standards as an Enabler for the Cloud Laboratory

Abstract:

Wei Liu_Headshot

Wei Liu, PhD

Scientist

Johnson & Johnson

WORLDWIDE

Talk Title:

High-Throughput Chemistry to Accelerate Drug Discovery

Abstract:

2022 CLOUD LAB, HTE, & LAB AUTOMATION VIRTUAL CONFERENCE (Year 2)

Conference Recordings

CloudLab LinkedIn Image
Cloud Lab Speakers_2022
Cloud Lab Sponsor Logos_2022

CONFERENCE AGENDA